Cambridge based biotechnology company, Phico Therapeutics, has announced it has received £7 million in funding from a consortium of investors.  BGF, the UK and Ireland’s most active growth capital investor, led the round with a £3 million investment, while a further £4 million was received from existing backers.  Founded in 2000 by Dr Heather Fairhead, Phico is developing a biotechnology platform for a new generation of antibiotics to overcome antibacterial resistance.